Shopping Cart 0
Cart Subtotal
USD 0

Pacific Edge Ltd (PEB) - Product Pipeline Analysis, 2019 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. The company offers lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. PEB offers services such as molecular oncology, bioinformatics, cancer genetics, clinical research, technology commercialisation, marketing and sales, among others. The company offers diagnostic services through its facilities located in Australia, New Zealand, and the US. PEB is headquartered in Dunedin, New Zealand.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Pacific Edge Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Pacific Edge Ltd Company Overview

Pacific Edge Ltd Company Snapshot

Pacific Edge Ltd Pipeline Products and Ongoing Clinical Trials Overview

Pacific Edge Ltd-Pipeline Analysis Overview

Pacific Edge Ltd-Key Facts

Pacific Edge Ltd-Major Products and Services

Pacific Edge Ltd Pipeline Products by Development Stage

Pacific Edge Ltd Ongoing Clinical Trials by Trial Status

Pacific Edge Ltd Pipeline Products Overview

Cxbladder

Cxbladder Product Overview

Cxbladder Clinical Trial

Cxbladder-Health

Cxbladder-Health Product Overview

Cxbladder-Prognosis Assay

Cxbladder-Prognosis Assay Product Overview

Cxcolorectal-Prognosis Gen I

Cxcolorectal-Prognosis Gen I Product Overview

Cxcolorectal-Prognosis Gen II

Cxcolorectal-Prognosis Gen II Product Overview

Diagnostic Assay-Gastric Cancer

Diagnostic Assay-Gastric Cancer Product Overview

Endometrial Cancer Detection Assay

Endometrial Cancer Detection Assay Product Overview

Gastric Cancer Triage Immunoassay

Gastric Cancer Triage Immunoassay Product Overview

Prognostic Assay-Melanoma

Prognostic Assay-Melanoma Product Overview

Pacific Edge Ltd-Key Competitors

Pacific Edge Ltd-Key Employees

Pacific Edge Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Pacific Edge Ltd, Recent Developments

May 29, 2019: Pacific Edge reports continued growth in FY19

May 20, 2019: International Urology experts present on Cxbladder

Apr 18, 2019: Pacific Edge appoints John Duncan to the Board as an Independent Director

Aug 16, 2018: Another of New Zealand's Public Healthcare providers, Hauora Tairawhiti, adopts Cxbladder

May 29, 2018: Pacific Edge Announces Preliminary Results for Year Ended 31 March 2018

May 24, 2018: Cxbladder Monitor Demonstrates Clinical Utility In Patients Being Monitored For Recurrent Bladder Cancer (UC)

Nov 29, 2017: Pacific Edge: FY18 Interim Results

Aug 03, 2017: Cxbladder Test Suite Adopted by MidCentral DHB

May 24, 2017: Pacific Edge: Full Year Results to 31 March 2017

Apr 12, 2017: Cxbladder Monitor Significantly Outperforms All Compared FDA Approved Urine Tests For Bladder Cancer; Enhancing The Standard Of Care For Bladder Cancer Patients

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Pacific Edge Ltd Pipeline Products by Equipment Type

Pacific Edge Ltd Pipeline Products by Development Stage

Pacific Edge Ltd Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Pacific Edge Ltd Pipeline Products and Ongoing Clinical Trials Overview

Pacific Edge Ltd Pipeline Products by Equipment Type

Pacific Edge Ltd Pipeline Products by Indication

Pacific Edge Ltd Ongoing Clinical Trials by Trial Status

Pacific Edge Ltd, Key Facts

Pacific Edge Ltd, Major Products and Services

Pacific Edge Ltd Number of Pipeline Products by Development Stage

Pacific Edge Ltd Pipeline Products Summary by Development Stage

Pacific Edge Ltd Ongoing Clinical Trials by Trial Status

Pacific Edge Ltd Ongoing Clinical Trials Summary

Cxbladder-Product Status

Cxbladder-Product Description

Cxbladder-A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urothelial Carcinoma (UC)

Cxbladder-Health-Product Status

Cxbladder-Health-Product Description

Cxbladder-Prognosis Assay-Product Status

Cxbladder-Prognosis Assay-Product Description

Cxcolorectal-Prognosis Gen I-Product Status

Cxcolorectal-Prognosis Gen I-Product Description

Cxcolorectal-Prognosis Gen II-Product Status

Cxcolorectal-Prognosis Gen II-Product Description

Diagnostic Assay-Gastric Cancer-Product Status

Diagnostic Assay-Gastric Cancer-Product Description

Endometrial Cancer Detection Assay-Product Status

Endometrial Cancer Detection Assay-Product Description

Gastric Cancer Triage Immunoassay-Product Status

Gastric Cancer Triage Immunoassay-Product Description

Prognostic Assay-Melanoma-Product Status

Prognostic Assay-Melanoma-Product Description

Pacific Edge Ltd, Key Employees

Pacific Edge Ltd, Subsidiaries

Glossary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Pacific Edge Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Rubicon Ltd.

Metlifecare Ltd

Fisher & Paykel Healthcare Corporation Ltd

Summary

Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. The company offers lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. PEB offers services such as molecular oncology, bioinformatics, cancer genetics, clinical research, technology commercialisation, marketing and sales, among others. The company offers diagnostic services through its facilities located in Australia, New Zealand, and the US. PEB is headquartered in Dunedin, New Zealand.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Pacific Edge Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Pacific Edge Ltd Company Overview

Pacific Edge Ltd Company Snapshot

Pacific Edge Ltd Pipeline Products and Ongoing Clinical Trials Overview

Pacific Edge Ltd-Pipeline Analysis Overview

Pacific Edge Ltd-Key Facts

Pacific Edge Ltd-Major Products and Services

Pacific Edge Ltd Pipeline Products by Development Stage

Pacific Edge Ltd Ongoing Clinical Trials by Trial Status

Pacific Edge Ltd Pipeline Products Overview

Cxbladder

Cxbladder Product Overview

Cxbladder Clinical Trial

Cxbladder-Health

Cxbladder-Health Product Overview

Cxbladder-Prognosis Assay

Cxbladder-Prognosis Assay Product Overview

Cxcolorectal-Prognosis Gen I

Cxcolorectal-Prognosis Gen I Product Overview

Cxcolorectal-Prognosis Gen II

Cxcolorectal-Prognosis Gen II Product Overview

Diagnostic Assay-Gastric Cancer

Diagnostic Assay-Gastric Cancer Product Overview

Endometrial Cancer Detection Assay

Endometrial Cancer Detection Assay Product Overview

Gastric Cancer Triage Immunoassay

Gastric Cancer Triage Immunoassay Product Overview

Prognostic Assay-Melanoma

Prognostic Assay-Melanoma Product Overview

Pacific Edge Ltd-Key Competitors

Pacific Edge Ltd-Key Employees

Pacific Edge Ltd-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Recent Developments

Pacific Edge Ltd, Recent Developments

May 29, 2019: Pacific Edge reports continued growth in FY19

May 20, 2019: International Urology experts present on Cxbladder

Apr 18, 2019: Pacific Edge appoints John Duncan to the Board as an Independent Director

Aug 16, 2018: Another of New Zealand's Public Healthcare providers, Hauora Tairawhiti, adopts Cxbladder

May 29, 2018: Pacific Edge Announces Preliminary Results for Year Ended 31 March 2018

May 24, 2018: Cxbladder Monitor Demonstrates Clinical Utility In Patients Being Monitored For Recurrent Bladder Cancer (UC)

Nov 29, 2017: Pacific Edge: FY18 Interim Results

Aug 03, 2017: Cxbladder Test Suite Adopted by MidCentral DHB

May 24, 2017: Pacific Edge: Full Year Results to 31 March 2017

Apr 12, 2017: Cxbladder Monitor Significantly Outperforms All Compared FDA Approved Urine Tests For Bladder Cancer; Enhancing The Standard Of Care For Bladder Cancer Patients

Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Pacific Edge Ltd Pipeline Products by Equipment Type

Pacific Edge Ltd Pipeline Products by Development Stage

Pacific Edge Ltd Ongoing Clinical Trials by Trial Status


List Of Table

List of Tables

Pacific Edge Ltd Pipeline Products and Ongoing Clinical Trials Overview

Pacific Edge Ltd Pipeline Products by Equipment Type

Pacific Edge Ltd Pipeline Products by Indication

Pacific Edge Ltd Ongoing Clinical Trials by Trial Status

Pacific Edge Ltd, Key Facts

Pacific Edge Ltd, Major Products and Services

Pacific Edge Ltd Number of Pipeline Products by Development Stage

Pacific Edge Ltd Pipeline Products Summary by Development Stage

Pacific Edge Ltd Ongoing Clinical Trials by Trial Status

Pacific Edge Ltd Ongoing Clinical Trials Summary

Cxbladder-Product Status

Cxbladder-Product Description

Cxbladder-A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urothelial Carcinoma (UC)

Cxbladder-Health-Product Status

Cxbladder-Health-Product Description

Cxbladder-Prognosis Assay-Product Status

Cxbladder-Prognosis Assay-Product Description

Cxcolorectal-Prognosis Gen I-Product Status

Cxcolorectal-Prognosis Gen I-Product Description

Cxcolorectal-Prognosis Gen II-Product Status

Cxcolorectal-Prognosis Gen II-Product Description

Diagnostic Assay-Gastric Cancer-Product Status

Diagnostic Assay-Gastric Cancer-Product Description

Endometrial Cancer Detection Assay-Product Status

Endometrial Cancer Detection Assay-Product Description

Gastric Cancer Triage Immunoassay-Product Status

Gastric Cancer Triage Immunoassay-Product Description

Prognostic Assay-Melanoma-Product Status

Prognostic Assay-Melanoma-Product Description

Pacific Edge Ltd, Key Employees

Pacific Edge Ltd, Subsidiaries

Glossary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Pacific Edge Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

Rubicon Ltd.

Metlifecare Ltd

Fisher & Paykel Healthcare Corporation Ltd

chat_bubbleLet's Chat